Brought to you by 
F-star brings in €17mm through its Series A round
14 Apr 2011
Executive Summary
F-star (antibody engineering) has raised €9mm ($13.4mm) through the closing of its Series A venture round. New backer Aescap Venture and returning investor Atlas Venture provided the funding for the €6mm tranche in September, and its latest €3mm came from Novo AS, a first-time shareholder.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Synthesis Technologies, Production Processes
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
F-star brings in €17mm through its Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice